Figure 1
Figure 2
Figure 3
Figure 4
Patient characteristics
| Patient N° | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| Sex | M | M | F | M | M | M | M |
| Age (years) | 41 | 58 | 64 | 74 | 71 | 45 | 55 |
| No of cycles at first eye exam | 2 | 11 | 15 | 3 | 3 | 3 | 6 |
| No of cycles at last eye exam | 3 | 13 | 24 | 8 | 5 | 4 | 7 |
| Change in dosage | yes adjusted dose = lower dose due to the cutaneous side effects | no | no | no | no | no | no |
| BCVA RE | 1.0 | 1.0 | 1.0 | 0.7 – 0.9 | 0.8 | 1.0 | 1.0 |
| BCVA LE | 1.0 | 1.0 | 1.0 | 0.7 – 0.9 | 0.7 | 1.0 | 1.0 |
| Symptoms | circle centrally | blurred vision | no | blurred vision | floaters in LE, blurred vision | circle centrally | no |
| Occurrence of symptoms after starting the therapy | 1 week | 1 week | - | 1 week | 1 month | 1 week | - |
| Fluctuations of symptoms | spontan. resolution | no | - | different spectacles needed | better after topical therapy | spontan. resolution | needs spectacles |
| OCT changes in the fovea | elongatio of IZ | SRF | SRF | SRF | elongation of IZ in RE, SRF in LE | SRF | SRF |
| Extrafoveal SRF | multiple bilateral | multiple bilateral | multiple bilateral | multiple bilateral | no | no | multiple bilateral |
| Other ocular findings | - | - | - | incipient senile cataract ou | uveitis in LE; incipient cataract ou | - | dilatated conjuctival vessels in the RE |